| CSGYX | VISGX | CSGYX / VISGX | |
| Total Expense Ratio | 0.85 | 0.19 | 447% |
| Annual Report Gross Expense Ratio | 0.85 | 0.19 | 447% |
| Fund Existence | 16 years | 28 years | - |
| Gain YTD | 21.506 | 11.683 | 184% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.95B | 39.7B | 7% |
| Annual Yield % from dividends | 0.00 | 0.43 | - |
| Returns for 1 year | 13.93 | 4.88 | 285% |
| Returns for 3 years | 83.90 | 50.44 | 166% |
| Returns for 5 years | 11.98 | 22.65 | 53% |
| Returns for 10 years | 112.71 | 167.11 | 67% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LMOFX | 50.46 | 0.44 | +0.88% |
| Patient Opportunity FI | |||
| HFQAX | 7.20 | 0.03 | +0.42% |
| Janus Henderson Global Equity Income A | |||
| JRSTX | 11.95 | 0.04 | +0.34% |
| JH Adaptive Risk Mgd U.S. Eq T | |||
| CLTAX | 17.89 | 0.05 | +0.28% |
| Catalyst/Lyons Tactical Allocation A | |||
| DNFGX | 42.63 | -0.03 | -0.07% |
| Dunham Focused Large Cap Growth N | |||